Raymond James Downgrades Haemonetics (HAE) to Outperform, Removed from Analyst Current Favorite list
Tweet Send to a Friend
Raymond James analyst Andrew Cooper downgraded Haemonetics (NYSE: HAE) from Strong Buy to Outperform with a price target of $78.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
